Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.87%335.36B | -9.27%325.53B | -12.23%308.78B | -8.23%1.35T | -8.99%345.28B | -2.69%358.81B | -2.11%351.79B | -2.09%1.47T | -7.39%361.93B | -2.00%379.39B |
| Cost of revenue | -6.54%143.1B | -8.67%144.19B | -11.93%135.92B | -5.73%598.68B | -4.20%153.12B | 0.21%157.88B | -3.10%154.33B | -1.82%635.09B | -8.19%158.44B | -4.39%159.84B |
| Gross profit | 0.05%192.27B | -9.75%181.34B | -12.46%172.86B | -10.13%749.8B | -12.48%192.16B | -4.85%200.93B | -1.32%197.46B | -2.30%834.33B | -6.76%203.5B | -0.19%219.55B |
| Operating expense | -11.33%119.65B | 7.90%141.57B | 26.51%151.34B | 18.77%526.82B | 11.01%134.93B | 15.15%131.2B | 55.67%119.63B | 3.19%443.56B | 7.57%131.26B | 19.13%121.55B |
| Selling and administrative expenses | -7.59%123.4B | -2.09%128.37B | 12.89%135.32B | 13.19%527.48B | 10.27%133.54B | 14.98%131.11B | 11.38%119.87B | 9.17%466.02B | 5.37%123.29B | 10.97%121.11B |
| -General and administrative expense | -7.59%123.4B | -2.09%128.37B | 12.89%135.32B | 13.19%527.48B | 10.27%133.54B | 14.98%131.11B | 11.38%119.87B | 9.17%466.02B | 5.37%123.29B | 10.97%121.11B |
| Other operating expenses | ---- | 155.68%14.93B | 626.12%16.57B | 21.06%19.31B | 23.69%2.64B | 155.42%5.84B | 29.51%2.28B | -22.72%15.95B | 39.00%9.76B | -9.80%2.14B |
| Total other operating income | 201.12%3.76B | -69.88%1.73B | -78.17%551M | -48.02%19.96B | -26.46%1.25B | 141.64%5.75B | -92.24%2.52B | 117.25%38.4B | -10.51%1.79B | -82.08%1.7B |
| Operating profit | 26.89%72.62B | -42.96%39.78B | -72.35%21.53B | -42.94%222.98B | -41.61%57.23B | -28.28%69.73B | -36.85%77.84B | -7.87%390.77B | -24.92%72.24B | -16.90%98.01B |
| Net non-operating interest income (expenses) | 208.03%47.56B | -5,267.13%-235.67B | -61.76%5.32B | 30.95%41.13B | 207.92%15.44B | -70.75%4.56B | 209.45%13.92B | 150.76%31.41B | -72.55%6.3B | 122.53%5.01B |
| Non-operating interest income | 137.41%52.32B | -48.07%4.01B | -45.27%9.88B | 36.59%52.1B | 140.50%22.04B | -54.54%7.71B | 188.11%18.05B | 2,607.03%38.14B | 751.32%6.47B | 3,438.22%9.16B |
| Non-operating interest expense | -27.79%4.77B | 7,504.00%239.68B | 10.23%4.56B | 62.91%10.97B | 59.04%6.6B | 129.57%3.15B | 133.82%4.13B | -89.36%6.74B | 100.75%166M | -81.57%4.15B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -16.81%-132M | -160M | -78M | -272M | -113M | 0 | ||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 65.45%120.05B | -363.91%-196.06B | -70.82%26.77B | -37.51%263.83B | -29.57%72.56B | -34.15%74.29B | -28.19%91.75B | 16.53%422.17B | -34.10%78.54B | 7.68%103.02B |
| Income tax | 13.49%13.72B | -63.37%5.33B | -93.96%707M | -47.67%44.41B | -56.14%12.09B | -34.12%14.54B | -47.92%11.71B | -19.57%84.86B | -73.37%12.74B | 32.37%27.56B |
| Net income | 75.84%106.33B | -437.04%-201.38B | -67.44%26.06B | -34.95%219.42B | -19.87%60.47B | -34.16%59.75B | -23.97%80.04B | 31.37%337.31B | -7.76%65.8B | 0.81%75.46B |
| Net income continuous operations | 75.84%106.33B | -437.04%-201.38B | -67.44%26.06B | -34.95%219.42B | -19.87%60.47B | -34.16%59.75B | -23.97%80.04B | 31.37%337.31B | -7.76%65.8B | 0.81%75.46B |
| Noncontrolling interests | 144.10%71M | -118.75%-35M | -67.44%56M | 50.22%338M | -219.26%-161M | -108.70%-16M | 186.67%172M | 45.16%225M | -18.46%-154M | -8.16%135M |
| Net income attributable to the company | 75.26%106.26B | -436.89%-201.35B | -67.44%26.01B | -35.01%219.08B | -19.51%60.63B | -34.01%59.77B | -24.09%79.87B | 31.36%337.09B | -7.72%65.95B | 0.83%75.33B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 75.26%106.26B | -436.89%-201.35B | -67.44%26.01B | -35.01%219.08B | -19.51%60.63B | -34.01%59.77B | -24.09%79.87B | 31.36%337.09B | -7.72%65.95B | 0.83%75.33B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 73.35%58.66 | -433.61%-111.46 | -67.75%14.48 | -35.44%122.51 | -20.53%33.84 | -34.95%33.41 | -23.25%44.9 | 37.85%189.77 | -6.11%37.17 | 1.89%42.58 |
| Diluted earnings per share | 73.00%58.04 | -437.35%-111.46 | -67.71%14.3 | -35.05%120.85 | -19.79%33.55 | -34.43%33.04 | -23.03%44.28 | 37.99%186.07 | -5.75%36.41 | 1.70%41.83 |
| Dividend per share | 0 | 0 | 0 | 0.00%28 | 0 | 0 | 0 | 28 | 28 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |